Activities per year
Activities
- 50 - 100 out of 194 results
Search results
-
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (Journal)
Jonathan Douxfils (Peer reviewer)
2017 → …Activity: Publication peer-review and editorial work types › Publication peer-review
-
Clinical Case Reports (Journal)
Jonathan Douxfils (Peer reviewer)
2016 → …Activity: Publication peer-review and editorial work types › Publication peer-review
-
Clinical Chemistry and Laboratory Medicine (Journal)
Jonathan Douxfils (Peer reviewer)
2014 → …Activity: Publication peer-review and editorial work types › Publication peer-review
-
Clinical Debate: There is a need for DOAC testing in emergency situations and elective preoperative setting - YES
Jonathan Douxfils (Invited speaker)
14 Jun 2019Activity: Talk or presentation types › Oral presentation
-
Clinical Pharmacology in Drug Development (Journal)
Jonathan Douxfils (Peer reviewer)
2013 → …Activity: Publication peer-review and editorial work types › Publication peer-review
-
Combined Hormonal Contraceptives - Induced Coagulopathies Evaluation of the Prothrombotic State Using a Global Coagulation Assay
Jonathan Douxfils (Speaker) & Laure Morimont (Speaker)
4 Oct 2023Activity: Talk or presentation types › Invited talk
-
Congrès scientifique: L'Innovation contre le cancer
Jonathan Douxfils (Keynote Speaker)
22 Sept 2016Activity: Participating in or organising an event types › Participation in workshop, seminar, course
-
Contribution des techniques de coagulation à la compréhension de la physiologie et de la physiopathologie de l’hémostase – Applications cliniques
Jonathan Douxfils (Jury Member)
4 May 2021Activity: Examinations › External Thesis
-
Correlation between activated protein C Resistance and the Relative Risk of Venous Thromboembolism in Women Using Hormonal Therapy
Laure Morimont (Speaker) & Jonathan Douxfils (Speaker)
11 May 2022 → 14 May 2022Activity: Talk or presentation types › Oral presentation
-
DOACs: new test on development
Jonathan Douxfils (Speaker)
2 Mar 2018Activity: Talk or presentation types › Oral presentation
-
Donesta Partner Meeting : Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Jonathan Douxfils (Keynote speaker)
4 Sept 2023 → 8 Sept 2023Activity: Talk or presentation types › Invited talk
-
Drug monitoring of direct oral anticoagulants: Key considerations and prespectives
Jonathan Douxfils (Speaker)
3 Nov 2022Activity: Talk or presentation types › Invited talk
-
Drugs (Journal)
Jonathan Douxfils (Peer reviewer)
2014 → …Activity: Publication peer-review and editorial work types › Publication peer-review
-
Drug Safety (Journal)
Jonathan Douxfils (Peer reviewer)
2014 → …Activity: Publication peer-review and editorial work types › Publication peer-review
-
EDOXABAN – LIXIANA®Un inhibiteur direct du FXa approuvé dans la prévention des AVC et emboles systémiques dans la fibrillation auriculaire non-valvulaire
Jonathan Douxfils (Consultant)
26 Feb 2018Activity: Consultancy types › Consultancy
-
Educational I - Should we measure DOACs?
Jonathan Douxfils (Invited speaker)
22 Nov 2018Activity: Talk or presentation types › Oral presentation
-
Effect of dabigatran etexilate on the risk of myocardial infarction and other cardiac events: A systematic review and updated dose-response meta-analysis of randomized controlled trials
Jonathan Douxfils (Speaker)
1 Jul 2013Activity: Talk or presentation types › Oral presentation
-
EMA Workshop Meeting - The role of pharmacokinetic and pharmacodynamic measurements in the use of direct oral anticoagulants (DOACs)
Jonathan Douxfils (Speaker)
23 Nov 2015Activity: Participating in or organising an event types › Participation to a Symposium, a study Day
-
Estétrol: une nouvelle ère dans la contraception
Jonathan Douxfils (Invited speaker)
11 Feb 2023Activity: Talk or presentation types › Invited talk
-
Estétrol/drospirénone, le point de vue de l’hém(ost)ato(sio)logue
Jonathan Douxfils (Speaker)
26 Jan 2022Activity: Talk or presentation types › Invited talk
-
Estetrol (E4): a native estrogen whose effect on the liver does not need to be counterbalanced by progestins
Jonathan Douxfils (Speaker)
27 May 2022Activity: Talk or presentation types › Oral presentation
-
Estetrol (E4): Impact on hemostasis
Jonathan Douxfils (Invited speaker)
24 May 2021Activity: Talk or presentation types › Invited talk
-
European Medicines Agency (External organisation)
Jonathan Douxfils (Member)
Feb 2012 → …Activity: Membership types › Membership of network
-
European Medicines Agency (External organisation)
Valentine Minet (Member)
Feb 2014 → …Activity: Membership types › Membership of council
-
Évaluation du risque vasculaire des contraceptifs
Jonathan Douxfils (Invited speaker)
21 Jun 2023 → 23 Jun 2023Activity: Talk or presentation types › Invited talk
-
Expert Opinion On Drug Safety (Journal)
Jonathan Douxfils (Peer reviewer)
2014 → …Activity: Publication peer-review and editorial work types › Publication peer-review
-
Expert Review of Pharmacoeconomics & Outcomes Research (Journal)
Jonathan Douxfils (Peer reviewer)
2019 → …Activity: Publication peer-review and editorial work types › Publication peer-review
-
Fantastic 4 - E4stetrol in Women's Health
Jonathan Douxfils (Invited speaker) & Jean-Michel Foidart (Invited speaker)
4 May 2023 → 6 May 2023Activity: Talk or presentation types › Oral presentation
-
FIGO - XXIVe World Congress of Gynecology and Obstetrics
Jonathan Douxfils (Speaker)
9 Oct 2023 → 13 Oct 2023Activity: Participating in or organising an event types › Participation in conference
-
Formation en sécurité de laboratoire : biosécurité - radioprotection - risque chimique
Valentine Minet (Participant)
12 Feb 2013 → 15 Feb 2013Activity: Participating in or organising an event types › Participation in workshop, seminar, course
-
Formation pour bio-technicien/memorant/doctorant (formation de type FELASA B) Certificat universitaire en science des animaux de laboratoire
Valentine Minet (Participant)
1 Feb 2013 → 15 Apr 2013Activity: Participating in or organising an event types › Participation in workshop, seminar, course
-
Forum jeunes chercheurs
Valentine Minet (Contributor)
20 Jan 2014Activity: Participating in or organising an event types › Participation in workshop, seminar, course
-
Fund for Research Training in Industry and Agriculture (FRIA) (External organisation)
Jonathan Douxfils (Chair)
2021 → 2024Activity: Examinations › Jury
-
Global coagulation assays in the future of laboratory diagnostics of hemostasis and thrombosis - Interplay between platelets and coagulation
Jonathan Douxfils (Keynote speaker)
24 Nov 2022Activity: Talk or presentation types › Invited talk
-
Hamostaseologie (Journal)
Jonathan Douxfils (Peer reviewer)
2018 → …Activity: Publication peer-review and editorial work types › Publication peer-review
-
Hemocompatibility of manufactured nanoparticles: Guidelines proposal.
Julie Laloy (Speaker)
2013Activity: Talk or presentation types › Oral presentation
-
Hemocompatibility of nanoparticles: impact on fibrinolysis.
Julie Laloy (Speaker)
2014Activity: Talk or presentation types › Oral presentation
-
Hemostasis parameters with estetrol/drospirenone - why APC resistance matters
Jonathan Douxfils (Speaker)
30 Nov 2023Activity: Talk or presentation types › Invited talk
-
Hormonal contraception and the risk of venous thrombosis – facts and myths
Jonathan Douxfils (Speaker)
18 Nov 2022Activity: Talk or presentation types › Invited talk
-
How to Measure Lupus Anticoagulants During DOAC Treatment?
Jonathan Douxfils (Speaker)
12 Jul 2020Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Jonathan Douxfils (Speaker)
17 May 2022Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Jonathan Douxfils (Speaker)
7 Jun 2022Activity: Talk or presentation types › Invited talk
-
Impact of E4 on hemostasis — Key messages to understand its unique safety profile
Jonathan Douxfils (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
Impact of nanomaterials on human health: Strategies of the Namur Nanosafety Center (NNC).
Julie Laloy (Speaker)
2012Activity: Talk or presentation types › Oral presentation
-
Impact of progestagen alone or associated with estrogen on the coagulation: A state of the art in 2023
Jonathan Douxfils (Speaker)
1 Dec 2023Activity: Talk or presentation types › Invited talk
-
Innovative applications of global assays in hemostatis
Jonathan Douxfils (Jury Member)
15 Dec 2023Activity: Examinations › External Thesis
-
Interference of DOACs in coagulation tests
Jonathan Douxfils (Invited speaker)
9 Nov 2018Activity: Talk or presentation types › Oral presentation
-
International Conference on Nanotechnology in Medicine
Valentine Minet (Poster)
26 Feb 2014 → 28 Feb 2014Activity: Participating in or organising an event types › Participation in conference
-
International Conference on Nanotechnology in Medicine
Valentine Minet (Contributor)
26 Feb 2014 → 28 Feb 2014Activity: Participating in or organising an event types › Participation in conference
-
International Conference on Nanotheranostics (ICoN 2013)
Valentine Minet (Contributor)
26 Sept 2013 → 28 Sept 2013Activity: Participating in or organising an event types › Participation in conference